PUBLISHER: The Business Research Company | PRODUCT CODE: 1825700
PUBLISHER: The Business Research Company | PRODUCT CODE: 1825700
Diabetic wounds are slow-healing wounds that frequently affect individuals with diabetes. These wounds arise due to a combination of factors, such as neuropathy, poor circulation, and elevated blood sugar levels, which disrupt the healing process and increase the risk of infection and complications.
The products designed for diabetic wounds include wound care dressings, wound care devices, skin grafts and substitutes, growth factors, and others. Wound care dressings are specialized materials used directly on diabetic wounds to protect them from contamination and facilitate healing. The different types of wounds include neuropathic ulcer wounds, ischemic ulcer wounds, and neuro-ischemic ulcer wounds, with various end-users such as hospitals, specialty clinics, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The diabetic wounds market research report is one of a series of new reports from The Business Research Company that provides diabetic wounds market statistics, including diabetic wounds industry global market size, regional shares, competitors with a diabetic wounds market share, detailed diabetic wounds market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic wounds industry. This diabetic wounds market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The diabetic wounds market size has grown strongly in recent years. It will grow from $2.18 billion in 2024 to $2.33 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the increasing prevalence of diabetes, rise in advancements in wound care technology, growing awareness of diabetic wound management, improvements in healthcare infrastructure, rise in aging population.
The diabetic wounds market size is expected to see strong growth in the next few years. It will grow to $3.05 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the rising prevalence of diabetes, growing technological innovations in wound care, growing demand for personalized treatment solutions, advancements in wound healing materials, increasing investment in research and development. Major trends in the forecast period include the development of smart wound care products, integration of advanced biomaterials, use of regenerative medicine technologies, telehealth and remote monitoring, and advancements in nanotechnology for wound healing.
The forecast of 7.0% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of collagen-based matrices and hyperbaric oxygen components sourced from Italy and Brazil, thereby compromising limb salvage efforts and increasing wound care center costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rise in obesity cases is anticipated to drive the growth of the diabetic wounds market in the coming years. Obesity, a condition characterized by excessive body fat storage that can negatively impact health, is becoming increasingly common as people lead more sedentary lifestyles, spending more time sitting and less time engaging in physical activity. Obesity is associated with diabetic wounds because excess body fat can lead to insulin resistance, impairing blood sugar control and slowing the wound healing process. For instance, in May 2024, the UK's Office for Health Improvement and Disparities reported that from 2022 to 2023, an estimated 26.2% of adults were living with obesity, a slight increase from 25.9% in the previous year (2021 to 2022). Thus, the rise in obesity cases is contributing to the expansion of the diabetic wound market.
Leading companies in the diabetic wounds market are focusing on the development of 3-D hydrocellular wound dressings to improve the management and treatment of diabetic wounds. These dressings feature a unique three-dimensional structure that effectively manages moisture and absorbs exudate, creating an optimal environment for wound healing. For instance, in October 2022, Healthium Medtech, a medical device company based in India, launched Theruptor Novo, an innovative wound dressing designed for chronic wounds such as diabetic foot ulcers. It uses patented technology to physically kill microbes, reducing resistance and providing protection for up to 7 days. The 3-D hydrocellular design of the dressing also effectively manages moisture, promoting better healing.
In May 2023, LifeNet Health, a regenerative medicine solutions company based in the U.S., acquired the wound care division of Bioventus Inc. for $85 million. This acquisition aims to strengthen LifeNet Health's wound care solutions by incorporating Bioventus Inc.'s product, TheraSkin, and positioning the company as a stronger global leader in regenerative medicine. Bioventus Inc., a U.S.-based biotechnology company, specializes in advanced wound care, including TheraSkin, which enhances the healing process in diabetic foot ulcers.
Major companies operating in the diabetic wounds market are 3M Health Care, Medline Industries Inc., B. Braun Melsungen AG, Smith & Nephew plc, Coloplast A/S, Hartmann Group, ConvaTec Group Plc, Molnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Hollister Incorporated, Wright Medical Group N.V., Organogenesis Inc., MiMedx Group Inc., LifeNet Health, Biosense Webster Inc., Derma Sciences Inc., Kerecis, DermaRite Industries LLC, MediWound Ltd., Tissue Regenix Group plc, Systagenix Wound Management, XenoTherapeutics, Alliqua BioMedical Inc
North America was the largest region in the diabetic wounds market in 2024. The regions covered in the diabetic wounds market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the diabetic wounds market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The diabetic wounds market consists of sales of antibacterial creams, gels, negative pressure wound therapy (NPWT) systems, and wound cleansers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diabetic Wounds Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on diabetic wounds market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for diabetic wounds ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetic wounds market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.